http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CR-8248-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/D21H27-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65D81-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/D21H21-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65D85-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/D21H27-40
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
filingDate 2006-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d29bde16eeab62edf0424dfa7a0e386b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90106b372995e0c832c904c1aef3b42d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e846b9a53e43133618b9bc00cf05e691
publicationDate 2008-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CR-8248-A
titleOfInvention BETA CRYSTALINE FORM OF IVABRADINE CHLORHYDRATE, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
abstract Crsitalin Bd form of ivabradine hydrochloride according to the formula (I) of the present application, characterized by the diffraction digram X on the following powder, measured on a PANalytical X'Per Pro diffractometer with an X'Celerator detector, and expressed in terms of line position (Bragg angle 2 theta, expressed in degrees); line height (expressed in accounts), line area (expressed in accounts x degrees); width at half height of the lines ("FWHM, expressed in degrees) and interreticular distance d (expressed in A).
priorityDate 2005-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3045381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449401048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536366

Total number of triples: 32.